Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study

This study aimed to determine the frequency and pattern of complementary and alternative medicine (CAM) use in thalassemia patients in south of Iran. The survey was done using a validated questionnaire which was distributed among 122 thalassemia patients. Only 108 questionnaires were completed and t...

Full description

Bibliographic Details
Published in:	Journal of Traditional and Complementary Medicine
Main Authors:	Mohammadreza Bordbar, Mehdi Pasalar, Sanaz Safaei, Roza kamfiroozi, Sohelia Zareifar, Omidreza zekavat, Sezaneh Haghpanah
Format:	Article
Language:	English
Published:	Elsevier 2018-01-01
Subjects:	Complementary and alternative medicine Thalassemia Hemoglobinopathy Traditional Persian medicine Iran
Online Access:	http://www.sciencedirect.com/science/article/pii/S2225411017300536

Similar Items

Complementary and alternative medicine use among people living with HIV in Shiraz, Southern Iran
by: Seyed Hamdollah Mosavat, et al.
Published: (2023-10-01)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
by: Sezaneh Haghpanah, et al.
Published: (2020-09-01)

Renal complications in thalassemia
by: Joseph Sleiman, et al.
Published: (2018-04-01)

Use of complementary and alternative medicine and its related factors among pregnant women in Shiraz, South of Iran: A cross-sectional study
by: Hossein Molavi Vardanjani, et al.
Published: (2023-01-01)

The Prevalence of Using Traditional, Complementary, and Integrative Medicine by Patients with Epidermolysis Bullosa
by: Mohammad Mahdi Parvizi, et al.
Published: (2024-12-01)

Abnormalities in Haemoglobin Synthesis: Thalassemia and It’s Epidemiology
by: Retno Dwi Wulandari
Published: (2018-03-01)

Navigating ethical dilemmas in complementary and alternative medicine: a narrative review
by: Mohammad Sadegh Adel Mehraban, et al.
Published: (2024-04-01)

Thalassemias and Other Hemoglobinopathies in Former Yugoslavia
by: Efremov G
Published: (2008-01-01)

Analysis of survival data in thalassemia patients in Shiraz, Iran
by: Abdolreza Rajaeefard, et al.
Published: (2015-07-01)

Prevalence of Co-Inheritance of Alpha-Thalassemia with Beta-Thalassemia and Beta-Hemoglobinopathy in Ahvaz City
by: Najmaddin Saki, et al.
Published: (2013-09-01)

Complementary and alternative medicine use among cancer patients in Iran: A systematic review
by: Mohammad Yousefi, et al.
Published: (2024-03-01)

A Laboratory Approach Consideration for Thrombotic Risk Assessment in Transfusion-dependent Beta-thalassemia Major Utilizing Complete Blood Count Cell Population Data and Basic Screening Hemostatic Parameters
by: R. Yashica Gowda, et al.
Published: (2024-10-01)

Thalassemia: Pathophysiology, Diagnosis, and Advances in Treatment
by: Idris Zubairu Sadiq, et al.
Published: (2024-10-01)

Thalassemia, a human blood disorder
by: F. Shafique, et al.
Published: (2021-09-01)

Thalassemias: An Overview
by: Michael Angastiniotis, et al.
Published: (2019-03-01)

Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait
by: Lisa M. Shook, et al.
Published: (2025-02-01)

Complementary medicine use among Iranian cancer patients
by: Sajadian A.S, et al.
Published: (2005-07-01)

Molecular Diagnostics of ß-Thalassemia
by: Plaseska-Karanfilska Dijana, et al.
Published: (2012-12-01)

Spectrum of types of thalassemias and hemoglobinopathies: study in a tertiary level children hospital in Bangladesh
by: Waqar A. Khan, et al.
Published: (2017-05-01)

Methodological issues on “Stakeholder attitudes to the regulation of traditional and complementary medicine professions: a systematic review”
by: Meysam Shirzad, et al.
Published: (2022-03-01)

Critical Content Analysis of Narrative Version of Islamic Medicine
by: SA Mozaffarpur, et al.
Published: (2022-03-01)

Premarital Screening for Thalassemia Among Young Adults: A Study in Zabol, Sistan and Baluchistan Province of Iran
by: Omolbanin Sargazi-Aval, et al.
Published: (2022-12-01)

Determining the current prevalence of β-thalassemia variants in Jordan
by: Diya Hasan, et al.
Published: (2023-03-01)

Endocrine complications
by: Vincenzo de Sanctis
Published: (2018-04-01)

Optimal blood transfusion therapy in haemoglobinopathies
by: John Porter
Published: (2018-04-01)

Diagnostic strategies in hemoglobinopathy testing, the role of a reference laboratory in the USA
by: Jennifer L. Oliveira
Published: (2018-04-01)

Iron overload and chelation therapy in hemoglobinopathies
by: Rayan Bou-Fakhredin, et al.
Published: (2018-04-01)

Haemoglobinopathies care and cure: Have we reached the end?
by: John Porter
Published: (2018-04-01)

Heart disease in patients with haemoglobinopathies
by: Dimitrios Farmakis, et al.
Published: (2018-04-01)

Hepatitis C virus treatment advances for thalassaemia patients
by: George Papatheodoridis
Published: (2018-04-01)

1st Pan-Asian Conference on Haemoglobinopathies, 8-10 February 2012 Bangkok - Thailand
by: Thalassaemia international Federation, Thalassaemia Foundation of Thailand and Mahidol University
Published: (2012-09-01)

Informed choice in a multicultural world
by: Mary Petrou
Published: (2018-04-01)

Let’s talk about thal: How communication can improve quality of life
by: Laurice M. Levine
Published: (2018-04-01)

Adherence to treatment: Doctor vs patient perspective
by: Farrukh Shah, et al.
Published: (2018-04-01)

Global initiatives for improving quality healthcare by the Thalassaemia International Federation
by: Andreas Polynikis, et al.
Published: (2018-04-01)

PIGI ZOIS: Pioneering with credibility
by: Vasilios Perifanis, et al.
Published: (2018-04-01)

Patient care: Unmet needs globally
by: Michael Angastiniotis, et al.
Published: (2018-04-01)

TIF 2.0: The Thal e-Course and TIF expert patients’ programme for disease-related education and self-management skills in thalassaemia
by: Victoria Antoniadou, et al.
Published: (2018-04-01)

The prevalence of complementary and alternative medicine use in the general population of Babol, North of Iran, 2018
by: Reihaneh Moeini, et al.
Published: (2021-04-01)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with β-Thalassemia
by: Michele Malagù, et al.
Published: (2023-03-01)